Precision BioSciences, Inc. (DTIL) Financials
DTIL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 164.3 million | 135.3 million |
2023-06-30 | 181.7 million | 147.7 million |
2023-03-31 | 204.5 million | 164.3 million |
2022-12-31 | 238.2 million | 177.7 million |
DTIL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -23.5 million | 3.1 million |
2023-06-30 | -22.3 million | 3.9 million |
2023-03-31 | -32.2 million | 4.1 million |
2022-12-31 | -22.5 million | 4.5 million |
DTIL Net Income
No data available :(
DTIL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 122.2 million | - | 1.5 million |
2023-06-30 | 137.8 million | - | 5.7 million |
2023-03-31 | 158.1 million | 22.3 million | 4.3 million |
2022-12-31 | 189.6 million | 22.2 million | 4.8 million |
DTIL Shares Outstanding
DTIL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 436000 | 15.9 million | 9.6 million | - |
2023-06-30 | 1.1 million | 21.9 million | 9.8 million | - |
2023-03-31 | 721000 | 22.2 million | 11.1 million | - |
2022-12-31 | 632000 | 21.1 million | 10.1 million | - |
DTIL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 13.1 million | 2.0 million |
2023-06-30 | 19.8 million | 2.4 million |
2023-03-31 | 8.8 million | 2.3 million |
2022-12-31 | 10.6 million | 2.3 million |
DTIL
Price: $11.17
52 week price:
Earnings Per Share: -332.12 USD
P/E Ratio: -13.94
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 459600
Market Capitalization: 94.0 million